November 12, 2008 - Volume 22 - Issue 17
pp: 2227-2408
Subscribe to eTOC



Envelope-specific antibody response in HIV-2 infection: C2V3C3-specific IgG response is associated with disease progression

Marcelino, José Maria; Nilsson, Charlotta; Barroso, Helena; More

AIDS . 22(17):2257-2265, November 12, 2008.

Continuous improvement in the immune system of HIV-infected children on prolonged antiretroviral therapy

Weinberg, Adriana; Dickover, Ruth; Britto, Paula; More

AIDS . 22(17):2267-2277, November 12, 2008.


Viral resuppression and detection of drug resistance following interruption of a suppressive non-nucleoside reverse transcriptase inhibitor-based regimen

Fox, Zoe; Phillips, Andrew; Cohen, Cal; More

AIDS . 22(17):2279-2289, November 12, 2008.

Long-term immunologic response to antiretroviral therapy in low-income countries: a collaborative analysis of prospective studies

Nash, Denis; Katyal, Monica; Brinkhof, Martin WG; More

AIDS . 22(17):2291-2302, November 12, 2008.

Five-year outcomes of initial patients treated in Botswana's National Antiretroviral Treatment Program

Bussmann, Hermann; Wester, C William; Ndwapi, Ndwapi; More

AIDS . 22(17):2303-2311, November 12, 2008.

Antiretroviral treatment during pregnancy

Keiser, Olivia; Gayet-Ageron, Angèle; Rudin, Christoph; More

AIDS . 22(17):2323-2330, November 12, 2008.

Concise Communication

Editorial Comment


Does less frequent routine monitoring of patients on a stable, fully suppressed cART regimen lead to an increased risk of treatment failure?

Reekie, Joanne; Mocroft, Amanda; Sambatakou, Helen; More

AIDS . 22(17):2381-2390, November 12, 2008.

EDITORIAL COMMENT